Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis
Eric Balti, Sarah Verhaeghe, Vibeke Kruse, Stijn Roels, Peter Coremans
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Peripheral Neuropathies and Disorders · Pituitary Gland Disorders and Treatments
This article has been corrected to accurately reflect author Vibeke Kruse’s affiliations. The following affiliations have been added:
Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), University of Antwerp, Wilrijk, Belgium Department of Oncology, Antwerp University Hospital, Edegem, Belgium
The authors deeply regret that this was not noticed prior to publication.